ID   ATRX_RAT                Reviewed;         527 AA.
AC   P70486;
DT   02-NOV-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1997, sequence version 1.
DT   24-JUL-2024, entry version 127.
DE   RecName: Full=Transcriptional regulator ATRX;
DE            EC=3.6.4.12;
DE   AltName: Full=ATP-dependent helicase ATRX;
DE   AltName: Full=X-linked nuclear protein;
DE   AltName: Full=pABP-2;
DE   Flags: Fragment;
GN   Name=Atrx;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CHARACTERIZATION.
RC   STRAIN=Wistar; TISSUE=Embryonic brain;
RX   PubMed=8667030; DOI=10.1046/j.1471-4159.1996.67010089.x;
RA   Ohsawa K., Imai Y., Ito D., Kohsaka S.;
RT   "Molecular cloning and characterization of annexin V-binding proteins with
RT   highly hydrophilic peptide structure.";
RL   J. Neurochem. 67:89-97(1996).
RN   [2]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-112; SER-113; SER-114;
RP   SER-162; SER-345 AND SER-346, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Involved in transcriptional regulation and chromatin
CC       remodeling. Facilitates DNA replication in multiple cellular
CC       environments and is required for efficient replication of a subset of
CC       genomic loci. Binds to DNA tandem repeat sequences in both telomeres
CC       and euchromatin and in vitro binds DNA quadruplex structures. May help
CC       stabilizing G-rich regions into regular chromatin structures by
CC       remodeling G4 DNA and incorporating H3.3-containing nucleosomes.
CC       Catalytic component of the chromatin remodeling complex ATRX:DAXX which
CC       has ATP-dependent DNA translocase activity and catalyzes the
CC       replication-independent deposition of histone H3.3 in pericentric DNA
CC       repeats outside S-phase and telomeres, and the in vitro remodeling of
CC       H3.3-containing nucleosomes. Its heterochromatin targeting is proposed
CC       to involve a combinatorial readout of histone H3 modifications
CC       (specifically methylation states of H3K9 and H3K4) and association with
CC       CBX5. Involved in maintaining telomere structural integrity in
CC       embryonic stem cells probably implying recruitment of CBX5 to
CC       telomeres. May be involved in transcriptional regulation of telomeric
CC       repeat-containing RNA (TERRA). Acts as a negative regulator of
CC       chromatin incorporation of transcriptionally repressive histone
CC       MACROH2A1, particularily at telomeres. Participates in the allele-
CC       specific gene expression at the imprinted IGF2/H19 gene locus. On the
CC       maternal allele, required for the chromatin occupancy of SMC1 and CTCTF
CC       within the H19 imprinting control region (ICR) and involved in
CC       esatblishment of histone tails modifications in the ICR. Binds to zinc-
CC       finger coding genes with atypical chromatin signatures and regulates
CC       its H3K9me3 levels. Forms a complex with ZNF274, TRIM28 and SETDB1 to
CC       facilitate the deposition and maintenance of H3K9me3 at the 3' exons of
CC       zinc-finger genes (By similarity). {ECO:0000250|UniProtKB:P46100}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O = ADP + H(+) + phosphate; Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.12;
CC   -!- SUBUNIT: Interacts with DAXX to form the chromatin remodeling complex
CC       ATRX:DAXX. Probably binds EZH2. Binds annexin V in a calcium and
CC       phosphatidylcholine/phosphatidylserine-dependent manner. Interacts
CC       directly with CBX5 via the PxVxL motif. Interacts with RAD50, MRE11 and
CC       NBN; indicative for an association with the MRN complex. Interacts with
CC       histone MACROH2A1. Interacts with histone H3 peptides methylated at
CC       'Lys-10' with preferences H3K9me3 > H3K9me2 > H3K9me1. Interacts with
CC       histone H3 peptides unmethylated at 'Lys-5' (H3K4me0). Interacts with
CC       MECP2, SMC1 and SMC3. Interacts with SETDB1, TRIM28 and ZNF274 (By
CC       similarity). {ECO:0000250|UniProtKB:P46100}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Chromosome, telomere
CC       {ECO:0000250}. Nucleus, PML body {ECO:0000250}. Note=Associated with
CC       pericentromeric heterochromatin during interphase and mitosis, probably
CC       by interacting with CBX5/HP1 alpha. Colocalizes with histone H3.3,
CC       DAXX, HIRA and ASF1A at PML-nuclear bodies (By similarity).
CC       {ECO:0000250}.
CC   -!- DOMAIN: The ADD domain predominantly interacts with histone H3
CC       trimethylated at 'Lys-10'(H3K9me3) (and to a lesser extent H3 mono- or
CC       dimethylated at 'Lys-10') and simultanously to histone H3 unmethylated
CC       at 'Lys-5' (H3K4me0). The interaction with H3K9me3 is disrupted by the
CC       presence of H3K4me3 suggesting a readout of the combined histone H3
CC       methylation state (By similarity). {ECO:0000250}.
CC   -!- DOMAIN: Contains one Pro-Xaa-Val-Xaa-Leu (PxVxL) motif, which is
CC       required for interaction with chromoshadow domains. This motif requires
CC       additional residues -7, -6, +4 and +5 of the central Val which contact
CC       the chromoshadow domain.
CC   -!- PTM: Citrullinated by PADI4. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the SNF2/RAD54 helicase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D64059; BAA10936.1; -; mRNA.
DR   AlphaFoldDB; P70486; -.
DR   IntAct; P70486; 1.
DR   STRING; 10116.ENSRNOP00000070457; -.
DR   iPTMnet; P70486; -.
DR   PhosphoSitePlus; P70486; -.
DR   jPOST; P70486; -.
DR   UCSC; RGD:619795; rat.
DR   AGR; RGD:619795; -.
DR   RGD; 619795; Atrx.
DR   InParanoid; P70486; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0099115; C:chromosome, subtelomeric region; ISO:RGD.
DR   GO; GO:0000781; C:chromosome, telomeric region; ISS:UniProtKB.
DR   GO; GO:0000779; C:condensed chromosome, centromeric region; ISO:RGD.
DR   GO; GO:0000792; C:heterochromatin; ISO:RGD.
DR   GO; GO:0000228; C:nuclear chromosome; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0005721; C:pericentric heterochromatin; ISO:RGD.
DR   GO; GO:0016605; C:PML body; ISO:RGD.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016887; F:ATP hydrolysis activity; IEA:RHEA.
DR   GO; GO:0003682; F:chromatin binding; ISS:UniProtKB.
DR   GO; GO:0070087; F:chromo shadow domain binding; ISO:RGD.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0015616; F:DNA translocase activity; ISO:RGD.
DR   GO; GO:0004386; F:helicase activity; IEA:UniProtKB-KW.
DR   GO; GO:0042393; F:histone binding; ISS:UniProtKB.
DR   GO; GO:0035064; F:methylated histone binding; ISO:RGD.
DR   GO; GO:0072711; P:cellular response to hydroxyurea; ISS:UniProtKB.
DR   GO; GO:0006325; P:chromatin organization; ISS:UniProtKB.
DR   GO; GO:0006338; P:chromatin remodeling; ISS:UniProtKB.
DR   GO; GO:0070192; P:chromosome organization involved in meiotic cell cycle; ISO:RGD.
DR   GO; GO:0030330; P:DNA damage response, signal transduction by p53 class mediator; ISS:UniProtKB.
DR   GO; GO:0006281; P:DNA repair; IEA:UniProtKB-KW.
DR   GO; GO:0030900; P:forebrain development; ISO:RGD.
DR   GO; GO:0000212; P:meiotic spindle organization; ISO:RGD.
DR   GO; GO:0035264; P:multicellular organism growth; ISO:RGD.
DR   GO; GO:1904908; P:negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric; ISO:RGD.
DR   GO; GO:0006334; P:nucleosome assembly; ISS:UniProtKB.
DR   GO; GO:0010571; P:positive regulation of nuclear cell cycle DNA replication; ISS:UniProtKB.
DR   GO; GO:0032206; P:positive regulation of telomere maintenance; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0035128; P:post-embryonic forelimb morphogenesis; ISO:RGD.
DR   GO; GO:0070198; P:protein localization to chromosome, telomeric region; ISO:RGD.
DR   GO; GO:0031297; P:replication fork processing; ISS:UniProtKB.
DR   GO; GO:0072520; P:seminiferous tubule development; ISO:RGD.
DR   GO; GO:0060009; P:Sertoli cell development; ISO:RGD.
DR   GO; GO:0007283; P:spermatogenesis; ISO:RGD.
DR   GO; GO:0031509; P:subtelomeric heterochromatin formation; ISS:UniProtKB.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; ISO:RGD.
DR   InterPro; IPR052131; ATRX_domain-containing.
DR   PANTHER; PTHR46357; TRANSCRIPTIONAL REGULATOR ATRX; 1.
DR   PANTHER; PTHR46357:SF1; TRANSCRIPTIONAL REGULATOR ATRX; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Chromatin regulator; Chromosome; Citrullination; DNA damage;
KW   DNA repair; DNA-binding; Helicase; Hydrolase; Isopeptide bond;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Reference proteome; Telomere;
KW   Transcription; Transcription regulation; Ubl conjugation.
FT   CHAIN           <1..>527
FT                   /note="Transcriptional regulator ATRX"
FT                   /id="PRO_0000074306"
FT   REGION          1..527
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          290..427
FT                   /note="Interaction with DAXX"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        28..45
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        58..125
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        136..193
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        207..245
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        271..293
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        296..312
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        337..352
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        368..411
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        444..463
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        495..520
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         62
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P46100"
FT   MOD_RES         74
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P46100"
FT   MOD_RES         112
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         113
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         114
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         162
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         184
FT                   /note="Citrulline"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         345
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         346
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         354
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61687"
FT   MOD_RES         423
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P46100"
FT   MOD_RES         425
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P46100"
FT   MOD_RES         427
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P46100"
FT   MOD_RES         449
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P46100"
FT   MOD_RES         453
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P46100"
FT   CROSSLNK        105
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P46100"
FT   NON_TER         1
FT   NON_TER         527
SQ   SEQUENCE   527 AA;  59259 MW;  ABEF4B10C086D638 CRC64;
     GRSVVEFGDM VCKRQQSAVS SAGSEKPSGK EENVHSPEDK RVTKSKEKSK HLRTRTGRKV
     KSDVTDRFRK KEQSSESSEG EKKQGRQRTG TRGKKSTDLK EEKVKREREY ESSSDGTEKL
     PEGEEIGLFS KGVKQNKNDT TDEAKKGKKW KDKSCEKKEE LSDSVDRLPV KGESCDSSED
     KKTRNRVSLR EKKQFSLPAK SSGKRPECSS SDTERSVKGE CCDSTDKRVK RIDLRERRSS
     NSKRSTKEVK SGSSSSDAEG SSEDAKKQKK QRMSAKKKNS NTKERKRKSL RATTTKRKQA
     DITSSSSDIG DDDQNSAGEE SSDEQKIKPV TENLVLPSHT GFCQSSGDEA FSKSVPATVD
     DDDDDNDPEN RIAKKMLLEE IKANLSSDED GSSDDEPKEG EKKRIGKQSE ETPGDDGSNQ
     VNSESDSDSE ESKKPRYRHR LLRHKLSLSD GESGGEKKTK PKEHKETKGR NRRKVSSEDS
     EDTDFQESGV SEEVSESEDE QRPRTRSAKK AELEENQRSY KQKKKRR
//
